Nexgel, Inc · NASDAQ:NXGL
Nexgel — Investor Presentation (June 2025)
18 slides from Nexgel's investor presentation, Jun 4, 2025
Slide 1: NEXGEL Investor Presentation June 2025
XS —- \/ Ww NEXGEL Investor Presen June 2025 » @NEXGEL NASDAQ: NXGL \
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains certain forward-looking statements, including those relating to the Companys product development, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and o
Slide 3: NEXGEL - Who We Are and What We Do
NEXGEL - Who We Are and What We Do After two decades of creating custom hydrogel Agreements with Multi-Billion solutions for large medical device companies, our Dollar Corporations business today includes the development of patented medical devices, custom/white label ee products, and OTC healthcare
Slide 4: Multiple Products & Applications for Nexgel's Technology
Multiple Products & Applications for Nexgel’s Technology Branded White Label Products Custom & NEXGEL is Bringing proven Proprietary addressing the medical-grade consumer brands importance of technology to and accretive skin integrity OTC and Beauty M&A and overall & Cosmetics for opportunities skin
Slide 5: Competitive Advantage: State-of-the-Art Manufacturing Facilities in NA
Competitive Advantage: 1 of 2 State-of-the-Art Manufacturing Facilities in NA Medical grade technology and facility, providing gels to multi-national device companies for over 20 years with sufficient capacity to fulfill consumer and healthcare segments >1.4 Billion square inches 1 of 2 manufacturin
Slide 6: Converting and Packaging Facility
Converting and Packaging Facility 50% ownership in converting and packaging business in Granbury, Texas * Significant synergies which enable the onboarding of potential finished goods customers along with enhanced combined marketing and outreach efforts : Increased square footage and installed cutti
Slide 7: Hydrogels for Consumer and Medical Applications
Hydrogels for Consumer and Medical Applications + Electron beam technology eliminates the need for harmful chemicals in cross-linking, which, along with our paraben-free formulation, makes our patches the only option for many medical device applications and preferred among consumers + Gentle formula
Slide 8: Current Medical Device Pipeline
Current Medical Device Pipeline Addressing the importance of skin integrity and overall skincare with a medical device @NEXCEL NASDAQ: NXGL | | \
Slide 9: Medical Device Pipeline: Drug Delivery
Medical Device Pipeline: Drug Delivery Potential for Multiple Drug Delivery Applications through Unique Hydrogel Technology Drug Delivery: Diclofenac Patch To treat short-term pain due to preclinical sprains and bruises Drug Delivery: Apremilast Patch compara oalum from NEXGEL Paten After @Hours To
Slide 10: Consumer Health & Beauty
Consumer Health & Beauty Bringing proven medical-grade technologyto OTC and B&C for the first time through many new consumer products & applications @NEXGEL NASDAQ: NXGL
Slide 11: NEXGEL Branded Products
NEXGEL Branded Products oO ~ SilverSeal @NEXGEL NASDAQ: NXGL 1"
Slide 12: M&A Strategy: Consumer Brand Acquisition
M&A Strategy: Consumer Brand Acquisition Kenkoderm Skincare Line Silly George Beauty Brand + Acquisition completed in December 2023 + Acquisition completed in May 2024 + Complimentary line of alternative psoriasis treatments * Specialty eye and eyelash consumer product line + Profitable (ttm) and im
Slide 13: Cintas Corporation
Cintas Corporation Cintas is a leading provider of corporate identify uniforms, first aid and safety products and services to over 1 million businesses across North America * Cintas will distribute SilverSeal, NEXGEL’s hospital-grade dressing for wounds and burns to its customers in many sectors inc
Slide 14: STADA Arzneimittel AG
STADA Arzneimittel AG Partnership with European leader in consumer health supports expansion of NEXGEL OTC product portfolio @NEX STADA focuses on consumer healthcare products, generics and specialty pharm, selling products in approximately 120 countries across the world and this partnership will pr
Slide 15: AbbVie
AbbVie (NYSE: ABBV) CG Converting and Packaging is the exclusive supplier of gel pads to be used with AbbVie’s Rapid Acoustic Pulse device for the improvement in the appearance of cellulite + Allergan Aesthetics, acquired by AbbVie, purchased Soliton, the owner of the Resonic technology, for $550 mi
Slide 16: New Partnerships & Customers
New Partnerships & Customers Reducing Carcinogenic Plume in Laser Hair Removal An FDA-compliant IRB study conducted by Innovative Optics evaluating NEXGEL hydrogel's efficacy in reducing harmful plume during laser hair removal. * — 30-patient trial at Florida Clinical Research Center. + Data publica
Slide 17: Revenue for Q1'25
Revenue for Q1’'25 $3,000 $2,500 $2,000 $1,500 $1,000 $500 $0 $1.08M, +110% YOY $1.27M +104% YOY 012024 $2.94m $3.04 saveyor — *181%6Y0Y ga sim 121% YOY s14an 423% YOY 02 2024 03.2024 4 2024 1 2028 NASDAQ: NXGL. Highlights: QI 2025 Revenue: $2.81 million, +121% vs $1.27 million for Q1 2024 QI 2025 G
Slide 18: Contact Us
Contact Us Investor Relations: KCSA Strategic Communications Valter Pinto, Managing Director PH: (212) 896-1254 NEXGEL@KCSA.com NASDAQ: NXGL \ J) |